Skip to main content
Equibles
DYAI logo

DYAI · Dyadic International Inc · Earnings Call Transcripts & Audio

Track DYAI — free

Use DYAI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DYAI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.42 -0.06 (-12.50%) At close · Sep 14
Rebalance outlook locked
Going-concern doubt — flagged Aug 12, 2026

Substantial doubt about the company's ability to continue as a going concern.

“As of June 30, 2026, our management has concluded that there is substantial doubt about our ability to continue as a going concern, which depends upon our obtaining necessary financing to meet our obligations and repay our liabilities arising from normal business operations as they come due.”
View the 10-Q filed Aug 12, 2026
Market Cap
$15.46M
Shares
36.44M

Dyadic International Inc Earnings Call Transcripts

Quarterly earnings calls for Dyadic International Inc (DYAI), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲26.9% $879,597 −$1.81M '22 Q3 22-11-10 · $743,726 −$2.15M '22 Q4 23-03-29 ▲50.8% $978,052 −$956,444 '23 Q1 23-05-10 ▲27.1% $837,159 −$2.15M '23 Q2 23-08-09 ▼54.9% $397,060 −$1.61M '23 Q3 23-11-08 ▼7.7% $686,535 −$2.07M '23 Q4 24-03-28 ▼65.8% $334,617 −$2.01M '24 Q1 24-05-14 ▼53.9% $385,896 −$2.05M '24 Q2 24-08-13 ▲393% $1.96M −$203,460 '24 Q3 24-11-12 ▲19.1% $817,376 −$1.55M '24 Q4 25-04-23 ▲17.6% $393,572 −$2.03M '25 Q1 25-05-14 ▲150.5% $966,630 −$1.79M '25 Q2 25-08-13 ▼40.5% $1.16M −$1.98M '25 Q3 25-11-12 ▼30.8% $565,526 −$1.57M '25 Q4 26-03-25 ▲182.3% $1.11M −$1.95M '26 Q1 26-05-13 LATEST ▼0.6% $961,138 −$2.12M '26 Q2 26-08-12
Earnings call
FY26 · Q2
2026-08-12
Dyadic International Inc (DYAI) Q2 2026 Earnings Call Transcript
Positive tone Partner Programs and Revenue Ramp Going Concern and Liquidity Non-Dilutive Financing Strategy
Revenue
$961,138
▼ 0.6% YoY
Diluted EPS
$-0.06
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
Dyadic International Inc (DYAI) Q1 2026 Earnings Call Transcript
Confident tone Life sciences and cell culture media products Cultivated meat market opportunity Food, nutrition and dairy proteins
Revenue
$1.11M
▲ 182.3% YoY
Diluted EPS
$-0.05
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-25
Dyadic International Inc (DYAI) Q4 2025 Earnings Call Transcript
Confident tone Partnerships and distribution Life sciences / recombinant proteins Food and nutrition
Revenue
$565,526*
▼ 30.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-12
Dyadic International Inc (DYAI) Q3 2025 Earnings Call Transcript
Confident tone Life sciences portfolio (albumin, transferrin, DNase I, FGF) Commercial transformation and first product sales ProLiant Health and Biologics partnership (albumin)
Revenue
$1.16M
▼ 40.5% YoY
Diluted EPS
$-0.06
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-13
Dyadic International Inc (DYAI) Q2 2025 Earnings Call Transcript
Confident tone Life sciences / cell culture media products Bioindustrial and non-therapeutic market focus Food nutrition and dairy alternatives
Revenue
$966,630
▲ 150.5% YoY
Diluted EPS
$-0.06
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-14
Dyadic International Inc (DYAI) Q1 2025 Earnings Call Transcript
Positive tone Industrial enzymes and Fermbox Cell culture media and albumin Funded collaborations and grants
Revenue
$393,572
▲ 17.6% YoY
Diluted EPS
$-0.07
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-04-23
Dyadic International Inc (DYAI) Q4 2024 Earnings Call
Revenue
$817,376*
▲ 19.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Conference
Investor event
2025-03-30
Dyadic International Inc (DYAI) March 2025 Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY24 · Q3
2024-11-12
Dyadic International Inc (DYAI) Q3 2024 Earnings Call Transcript
Confident tone Alternative proteins commercialization (Dapibus platform) Life science / molecular biology product launches Cell culture media and cultured meat opportunity
Revenue
$1.96M
▲ 393% YoY
Diluted EPS
$-0.01
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-13
Dyadic International Inc (DYAI) Q2 2024 Earnings Call Transcript
Confident tone Proliant Partnership and Serum Albumin Cell Culture Media and Transferrin Non-Animal Dairy Products
Revenue
$385,896
▼ 53.9% YoY
Diluted EPS
$-0.07
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-14
Dyadic International Inc (DYAI) Q1 2024 Earnings Call Transcript
Confident tone Animal Health and H5N1 Bird Flu Regulatory Pathway and FDA Engagement Phase I DYAI-100 COVID Vaccine Results
Revenue
$334,617
▼ 65.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-28
Dyadic International Inc (DYAI) Q4 2023 Earnings Call Transcript
Confident tone Alternative proteins / Dapibus platform Animal health and infectious disease vaccines Equity-for-services deal strategy
Revenue
$686,535*
▼ 7.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-08
Dyadic International Inc (DYAI) Q3 2023 Earnings Call Transcript
Revenue
$397,060
▼ 54.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
Dyadic International Inc (DYAI) Q2 2023 Earnings Call Transcript
Revenue
$837,159
▲ 27.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-10
Dyadic International Inc (DYAI) Q1 2023 Earnings Call Transcript
Revenue
$978,052
▲ 50.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-29
Dyadic International Inc (DYAI) Q4 2022 Earnings Call Transcript
Revenue
$743,726*
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-10
Dyadic International Inc (DYAI) Q3 2022 Earnings Call Transcript
Revenue
$879,597
▲ 26.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-10
Dyadic International Inc (DYAI) Q2 2022 Earnings Call Transcript
Revenue
$658,553
▼ 29.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-12
Dyadic International Inc (DYAI) Q1 2022 Earnings Call Transcript
Revenue
$648,427
▼ 99.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-29
Dyadic International Inc (DYAI) Q4 2021 Earnings Call Transcript
Revenue
$*
▼ 133006.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-10
Dyadic International Inc (DYAI) Q3 2021 Earnings Call Transcript
Revenue
$692,929
▲ 66.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
Dyadic International Inc (DYAI) Q2 2021 Earnings Call Transcript
Revenue
$937,092
▲ 78.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
Dyadic International Inc (DYAI) Q1 2021 Earnings Call Transcript
Revenue
$460.52M
▲ 145924.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-30
Dyadic International Inc (DYAI) Q4 2020 Earnings Call Transcript
Revenue
$345,917*
▼ 20.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-12
Dyadic International Inc (DYAI) Q3 2020 Earnings Call Transcript
Revenue
$416,361
▼ 8.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-13
Dyadic International Inc (DYAI) Q2 2020 Earnings Call Transcript
Revenue
$524,271
▲ 34.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-14
Dyadic International Inc (DYAI) Q1 2020 Earnings Call Transcript
Revenue
$315,372
▼ 21.7% YoY
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-30
Dyadic International Inc (DYAI) Q4 2019 Earnings Call
Revenue
$433,168*
▼ 36.9% YoY
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–28 of 28 earnings calls
Key facts CIK 1213809 CUSIP 26745T101 13F (30d) 1 filings 1 filers Visit website